Titus Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.1M | Buy |
20,905
+34
| +0.2% | +$1.78K | 0.55% | 34 |
|
|
2022
Q1 | $1.08M | Buy |
20,871
+59
| +0.3% | +$3.06K | 0.49% | 34 |
|
|
2021
Q4 | $1.23M | Buy |
20,812
+15,357
| +282% | +$907K | 0.55% | 34 |
|
|
2021
Q3 | $235K | Sell |
5,455
-107
| -2% | -$4.61K | 0.12% | 143 |
|
|
2021
Q2 | $218K | Buy |
5,562
+14
| +0.3% | +$549 | 0.12% | 141 |
|
|
2021
Q1 | $201K | Sell |
5,548
-15,728
| -74% | -$570K | 0.12% | 138 |
|
|
2020
Q4 | $783K | Sell |
21,276
-383
| -2% | -$14.1K | 0.48% | 41 |
|
|
2020
Q3 | $754K | Buy |
21,659
+653
| +3% | +$22.7K | 0.54% | 37 |
|
|
2020
Q2 | $652K | Sell |
21,006
-59
| -0.3% | -$1.83K | 0.51% | 40 |
|
|
2020
Q1 | $652K | Buy |
21,065
+155
| +0.7% | +$4.8K | 0.62% | 35 |
|
|
2019
Q4 | $777K | Sell |
20,910
-130
| -0.6% | -$4.83K | 0.78% | 32 |
|
|
2019
Q3 | $717K | Buy |
21,040
+1,897
| +10% | +$64.6K | 0.66% | 35 |
|
|
2019
Q2 | $787K | Sell |
19,143
-1,618
| -8% | -$66.5K | 0.78% | 28 |
|
|
2019
Q1 | $837 | Buy |
20,761
+161
| +0.8% | +$6 | 0.74% | 29 |
|
|
2018
Q4 | $853 | Buy |
20,600
+2
| +0% | – | 0.73% | 21 |
|
|
2018
Q3 | $861K | Buy |
20,598
+366
| +2% | +$15.3K | 0.74% | 26 |
|
|
2018
Q2 | $698K | Buy |
20,232
+257
| +1% | +$8.87K | 0.75% | 24 |
|
|
2018
Q1 | $673K | Buy |
+19,975
| New | +$673K | 0.65% | 27 |
|